An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT01474291 · clinicaltrials.gov ↗

COMPLETED

Status

608

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Tocilizumab

Sponsor

Hoffmann-La Roche